Package 65219-642-02

Brand: dexmedetomidine hydrochloride

Generic: dexmedetomidine hydrochloride
NDC Package

Package Facts

Identity

Package NDC 65219-642-02
Digits Only 6521964202
Product NDC 65219-642
Product ID 65219-642_1896a96e-25f8-494e-9a96-6463b52fb102
Description

25 VIAL in 1 TRAY (65219-642-02) / 2 mL in 1 VIAL (65219-642-01)

Marketing

Marketing Status
Marketed Since 2024-12-13
Brand dexmedetomidine hydrochloride
Generic dexmedetomidine hydrochloride
Sample Package No

Linked Drug Pages (1)

Dexmedetomidine Hydrochloride ndc-match (0.95)

Raw FDA Data

View complete raw FDA NDC JSON payload 
{"route": ["INTRAVENOUS"], "spl_id": "1896a96e-25f8-494e-9a96-6463b52fb102", "openfda": {"unii": ["1018WH7F9I"], "rxcui": ["309710"], "spl_set_id": ["1896a96e-25f8-494e-9a96-6463b52fb102"], "manufacturer_name": ["Fresenius Kabi USA, LLC"], "is_original_packager": [true]}, "finished": true, "packaging": [{"sample": false, "description": "25 VIAL in 1 TRAY (65219-642-02)  / 2 mL in 1 VIAL (65219-642-01)", "package_ndc": "65219-642-02", "marketing_start_date": "20241213"}], "brand_name": "Dexmedetomidine Hydrochloride", "product_id": "65219-642_1896a96e-25f8-494e-9a96-6463b52fb102", "dosage_form": "INJECTION, SOLUTION", "pharm_class": ["Adrenergic alpha2-Agonists [MoA]", "Central alpha-2 Adrenergic Agonist [EPC]", "General Anesthesia [PE]"], "product_ndc": "65219-642", "generic_name": "dexmedetomidine hydrochloride", "labeler_name": "Fresenius Kabi USA, LLC", "product_type": "HUMAN PRESCRIPTION DRUG", "brand_name_base": "Dexmedetomidine Hydrochloride", "active_ingredients": [{"name": "DEXMEDETOMIDINE HYDROCHLORIDE", "strength": "100 ug/mL"}], "application_number": "ANDA201072", "marketing_category": "ANDA", "marketing_start_date": "20150918", "listing_expiration_date": "20271231"}